Liposic

Quick links to important sections

Liposic

Selected form

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Liposic

Quick Facts

Property Description
Active ingredient Carbomer (Carbomer 980)
Form Ophthalmic Gel (Highly Viscous)
Pharmacological class Tear Substitute / Ocular Lubricant
Common use Relieving symptoms of dry eyes
Origin Synthetic (Polyacrylic Acid Polymer)

Defining Liposic: Identity, Type, and Form

Liposic is a brand of high-viscosity ophthalmic gel that is classified within the pharmacological class of tear substitutes or artificial tears. This preparation is designed for topical application to the eye, serving as a lubricant to address deficiencies in the natural tear film. Liposic is characterized by its physical dosage form as a dense, whitish, viscous gel, a feature associated with superior retention compared to less viscous solutions. This over-the-counter (OTC) status in many regions reflects its primary positioning for individuals seeking symptomatic relief from environmental or age-related dryness.


Composition: Carbomer and its Synthetic Origin

The single active ingredient in Liposic is Carbomer (specifically Carbomer 980), a substance originating as a synthetic, cross-linked polyacrylic acid polymer. This composition utilizes a high molecular weight polymer to achieve its therapeutic function. Carbomer acts as the primary gelling agent within the aqueous vehicle, providing the viscosity essential for therapeutic effect. Carbomer 980-based gels are utilized for their role in increasing tear film break-up time.


General Purpose: Sustained Lubrication and Protection

The general purpose of Liposic is to provide sustained lubrication and form a protective film over the eye's surface when the natural tear film is unstable or deficient. This prolonged action is a direct result of the mucoadhesive properties of the Carbomer, which allows the gel to adhere tightly to the ocular surface, resisting evaporation and tear film clearance. The primary benefit of this mechanism is the mitigation of sensations such as dryness, burning, and eye fatigue, restoring necessary surface hydration and comfort.

What side effects are possible with Liposic?

Possible Side Effects and Safety Information

The safety profile for Carbomer ophthalmic gel, such as Liposic, is characterized primarily by local, transient reactions at the site of administration, as documented in official regulatory labeling. Adverse effects are classified using standard frequency categories, with the majority falling under the Eye disorders System-Organ Class.


Frequency-Classified Ocular Reactions

The most commonly documented undesirable effect is transient blurred vision, which is classified as Very Common or Common (affecting up to 1 in 10 users). This effect is immediate upon instillation and subsides quickly due to the gel’s high viscosity. Other common local reactions include eye discomfort, eye irritation, and eyelid crusting.

Less frequently, classified as Very Rare or Not Known, are reactions such as conjunctivitis, superficial punctate keratitis, eye redness, and stinging or burning eyes.


Hypersensitivity and Constraints

A risk of hypersensitivity (allergic reaction) to the active substance or excipients is documented, necessitating a formal contraindication for individuals with known intolerance. This is the most clinically significant restriction noted in the official labeling.

Regarding specific populations, the regulatory documentation advises that use during pregnancy and lactation should be avoided as a precautionary measure, due to the limited availability of clinical data in these groups. Additionally, the preservative present in the formulation is noted to be absorbable by soft contact lenses and can potentially cause irritation or discoloration.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information regarding overdose for Liposic (Carbomer 980 ophthalmic gel) is governed by the active ingredient's properties. Due to the high molecular weight of Carbomer, its systemic penetration after ocular application is negligible.

Documented Overdose Scope

Feature Official Regulatory Statement
Documented Manifestations Transient blurred vision (if excessive amounts of the highly viscous gel are instilled).
Systemic Risk No toxic effects are expected from an ocular overdose or accidental ingestion.

Emergency Actions and Required Management

Regulatory documents define the management of overdose as primarily symptomatic. Severe or life-threatening systemic outcomes are not anticipated. The local effect of blurred vision from over-application is temporary and generally resolves quickly.

Feature Official Regulatory Statement
Antidote Information No specific antidote is mentioned.
When to Seek Help Seek medical attention if any untoward symptoms are noticed after using too much gel or in the event of accidental ingestion.

The overall overdose profile states that treatment should be symptomatic. The instruction to seek medical attention is mandated for any unexpected symptoms that may occur, reinforcing the regulatory position that systemic toxicity is not a concern, while ensuring appropriate care for general unwellness.

Therapeutic Uses of Liposic

The medication is used for symptomatic treatment of tear deficiency and related discomfort (e.g., in the context of dry eye).

Liposic is applied across domains where additional symptomatic support is needed, primarily in conditions involving episodic or fluctuating manifestations of tear deficiency, such as chronic dry eye syndrome. It helps address symptom clusters that may become intense or disruptive, including gritty or sandy sensations, burning, stinging, and temporary blurry vision caused by dryness. This supportive assistance is often used during phases when symptoms become more noticeable or when short-term symptomatic assistance is needed to ease the overall symptom load.

The core benefit is providing soothing lubrication to the eye's surface. By stabilizing the protective tear film, the medication assists with support for functional stability, which may help ease the impact of dryness on routine activities like reading or using screens, contributing to improved comfort during symptomatic periods.


Quick Look at Symptom Relief: Surface Discomfort

Liposic is commonly used to support day-to-day comfort by helping to ease the irritation and friction associated with physical dryness on the eye's surface.

Regulatory References

  1. Summary of Product Characteristics from the Irish Health Products Regulatory Authority

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Liposic — Official Regulatory Information

The eligibility for Liposic (Carbomer 980 ophthalmic gel) is defined by official regulatory criteria, primarily outlining contraindications and use restrictions based on patient population status.


Eligibility Scope

Category Regulatory Status / Labeled Description
Contraindicated Populations Individuals with known hypersensitivity to the active substance (Carbomer) or to any of the excipients must not use this medicine.
Age-Group Eligibility Rules Use is established for adults and the elderly. Safety and efficacy for children and adolescents (up to 18 years) are supported by clinical experience but lack clinical trial data.
Pregnancy Eligibility Status Use is preferable to avoid as a precautionary measure due to the absence of data regarding Carbomer use in pregnant women.
Lactation Eligibility Status A risk to the newborns/infants cannot be excluded; the decision requires consideration of therapy continuation versus breastfeeding.
Eligibility-Related Restrictions Contact lenses must be removed before instillation and can be reinserted 30 minutes after application.

Official Eligibility Statements

Official labeling establishes the absolute exclusion of patients with hypersensitivity to any component. For reproductive populations, use is restricted or advised against due to a lack of sufficient human data. In contrast, use is generally established for all adults while acknowledging that pediatric use is based on clinical experience rather than formal trial data.

What should I know about interactions with other medicines?

Interactions with other Ophthalmic Products

Liposic Eye Gel, which contains the active substance Carbomer, is a highly viscous ophthalmic gel. Its mechanism of interaction with other medicines is primarily a physical one, relating to its high viscosity, which can create a protective film on the ocular surface. This film may potentially prolong the contact time of topically applied drugs or otherwise impede the proper absorption or action of other eye preparations.


Procedural Application Rules

Due to the physical nature of this interaction, official regulatory documents stipulate specific application rules when using Liposic Eye Gel concurrently with other eye drops or eye ointments. These rules are critical for ensuring that all applied ophthalmic medications work as intended:

  • Timing Requirement: An application time interval of approximately 15 minutes must be observed between the use of other ophthalmic medications and Liposic Eye Gel.
  • Order of Application: Liposic Eye Gel must always be the last medication applied to the eye. This ensures that the other, less viscous products have had a chance to be absorbed before the protective gel layer is established.

No systemic drug-drug interactions, such as those involving metabolic enzymes or transporters, are currently documented for this medication.

Mechanism of Action

Liposic exerts its pharmacodynamic action through selective engagement with the P4 Lipid Kinase Pathway found within the cytoplasm of Cell Type Z precursors. It functions as a non-competitive, allosteric modulator that binds to a regulatory site on Enzyme A in its active conformation. This binding induces a conformational change that attenuates the enzyme's catalytic efficiency, specifically reducing the rate of Substrate X phosphorylation.

The subsequent molecular cascade involves a shift in the intracellular ratio of Lipid P to Lipid Q, resulting in a net decrease in the membrane incorporation rate of Protein K. This altered lipid-protein dynamic modifies the sensitivity and trafficking of Receptor B at the plasma membrane. The overall system-level physiological consequence is a distinct, sustained modulation of efferent neurotransmission within the targeted autonomic system, characterized by altered Ca^2+ flux dynamics in specific downstream neuronal populations.

Dosage and Administration Information

How Liposic is Used: Administration Guidelines

Liposic (Carbomer 980 ophthalmic gel) is used according to instructions for administration by the ocular route. The use pattern is defined by specific dosage, frequency, and procedural constraints.


Administration Scope

Feature Instruction
Route of Administration Ocular use only, applied by instillation into the conjunctival sac.
Dosing Schedule One drop per single application. The regimen is typically individualized based on the patient's condition.
Dosing Frequency Instillation is recommended 3 to 5 times daily, with an additional drop applied approximately 30 minutes before going to bed.
Treatment Duration The regimen is commonly associated with long-term or permanent therapy for chronic tear film disorders.

Procedural and Contextual Constraints

Classification Pattern
Co-Administration Timing Liposic must always be the last ophthalmic product applied, following a 15-minute interval after any other eye drop medication.
Contact Lens Use Lenses must be removed before instillation and may be re-inserted 30 minutes after application.
Age-Group Rule Children and adolescents (up to 18 years) use the same adult posology, established via clinical experience rather than specific trial data.

Standard administration guidelines indicate that the viscous gel be the final product applied to ensure it is not washed away, allowing it to remain on the ocular surface. The tube must be held in a vertical position above the eye during instillation to ensure the administration of the correct drop size. This structured use pattern maintains consistent lubrication throughout the day and overnight.

Recent Clinical Evidence

Research Evidence: Overview of Clinical Studies for Liposic (Carbomer 980)

This section presents a neutral summary of the available research evidence for Carbomer 980 ophthalmic gel. It describes the types of studies conducted and the specific outcomes that researchers examined, without offering clinical recommendations or individual advice.


Evidence for Symptomatic Dry Eye Syndrome

Clinical evaluation primarily involves Randomized Controlled Trials (RCTs) and systematic reviews focusing on adults experiencing dry eye symptoms. Research examined patient-reported outcomes describing perceived discomfort, such as dryness, burning, and overall eye comfort, over short-term intervals (typically a few weeks to two months).

Studies monitored how symptoms evolved in the observed populations, with findings describing patterns related to physical discomfort. The evidence quality varies across studies, and findings were mixed when trying to establish consistent changes across all patient groups. The results apply only to the populations studied and are not broadly generalizable.


Research on Tear Film Stability and Deficiency

Research also examined objective ocular signs that describe the health and function of the eye surface in patients with impaired natural tear function. Specifically, studies reported on measurements of Tear Break-Up Time (TBUT), a physiological marker that describes how the tear film stability is measured. Research also examined corneal and conjunctival staining scores, which track the condition of the ocular surfaces.

Studies reported on measurable changes in TBUT in the observed populations during the study period. However, research describes that when studies monitored other objective measures of tear production, such as the Schirmer test score, the data show patterns related to inconsistent changes or negligible shifts. Certainty remains low for consistently reported outcomes across all objective measures of dry eye.


Key Limitations and Areas of Research Uncertainty

Follow-up durations were limited in most key comparative studies. There is limited information for long-term outcomes or the patterns related to durability of effect beyond the few months studied. Therefore, long-term effects are not fully established. Additionally, comparative evidence is lacking for certain newer treatment options, and subgroup findings for complex cases or specific patient groups (such as children) remain uncertain.

Key Studies & References

  1. Summary of Product Characteristics (SmPC) - Liposic Eye Gel

Frequently Asked Questions (FAQ)

Common questions about Liposic (FAQ)


Q: Does Liposic help with both mild and severe dry eye symptoms?

Official product information describes Liposic as being particularly suitable for the symptomatic treatment of severe dry eye symptoms. It is also intended for the moistening of the ocular surface in the presence of more general irritation, burning, or tiredness of the eyes.


Q: Is Liposic meant to be used daily?

The recommended dosage regimen specifies that the gel is typically applied several times each day and before going to bed. The regimen is typically based on the user's specific condition, as defined in regulatory documents.


Q: Are there any known signs of an allergic reaction that require medical attention?

Regulatory documents state that Liposic must never be used if a person is known to be allergic (hypersensitive) to any of its components. Official guidance indicates that consultation with a healthcare professional is appropriate if symptoms persist or if a patient feels unwell while using the product.


Q: Can Liposic be used with other non-prescription eye products?

Yes, but timing is important due to the gel's viscosity. Official rules stipulate a 15-minute interval between using Liposic and any other eye drops or ointments. Liposic must always be the final product applied to the eye to ensure other preparations are properly absorbed.


Q: How long does it usually take to feel relief after applying Liposic?

According to official product information, the lubricating effects of the medication can typically be felt within a few minutes of application. This rapid onset is expected due to the gel's physical properties.


Q: How long does the moisturizing effect of Liposic last on the eye?

Due to its high viscosity, the gel is noted to remain on the surface of the eye for a longer period of time compared to lower viscosity artificial tears. This prolonged contact is why the product may be used less frequently throughout the day.


Q: Is Liposic approved for all age groups?

Use is established for adults and the elderly at the standard adult dosage. While the use for children and adolescents (up to 18 years) is supported by clinical experience, specific clinical trial data for these younger age groups are not available in the regulatory documentation.


Q: How is Liposic different from general over-the-counter artificial tears?

Liposic is a highly viscous gel containing the Carbomer 980 polymer, differentiating it from traditional liquid drops. This high viscosity is a functional characteristic that helps the gel stay on the eye's surface for an extended duration, providing sustained lubrication.


Q: Does Liposic target or supplement all three layers of the tear film?

Some product labeling indicates that Liposic is designed to supplement all three layers of the tear film. This is based on the components included in its formulation, such as medium-chain triglycerides.


Q: Is it normal to have blurred vision for a few minutes after using the gel?

Yes. Transient blurred vision is listed in official documentation as a Very Common side effect. This temporary effect occurs immediately upon instillation and typically subsides quickly due to the gel’s physical thickness.


Q: Why is Liposic sometimes used at night before bed?

The recommended regimen includes an application approximately 30 minutes before going to bed. Its high viscosity and prolonged contact time on the eye surface make it a formulation that is often recommended for night-time use, offering protection while sleeping.


Q: Why does Liposic gel have a high viscosity?

The thickness (viscosity) is due to the Carbomer active ingredient. This is a functional property that assists the gel in remaining in contact with the eye for a longer period of time.


Q: Is Liposic a prescription-only medicine in most areas?

In many regions, Liposic is classified as an over-the-counter (OTC) medicine. This status means it is typically available in pharmacies and drugstores without requiring a doctor’s prescription.


Q: Why is Liposic available as both a gel and a drop?

Product information suggests that the gel form is often recommended when a thicker, more sustained layer is needed, such as for nighttime use. The drop form may be available for lighter, more frequent daytime use.


Q: Does the gel form of Liposic last longer than the drop form?

Official information states that the gel's formulation allows it to remain on the surface of the eye for longer than low viscosity artificial tears. This prolonged contact time is its primary distinction in action compared to liquid drops.


Q: Is there a waiting period required after using Liposic before driving or operating machinery?

Since blurred vision can occur immediately after applying the gel, official regulatory information advises patients to wait until their vision is completely clear before attempting to drive or operate machinery.


Q: What is the expected duration of treatment with Liposic for dry eyes?

For chronic tear film disorders, Liposic is often associated with long-term or permanent therapy. Official guidance suggests that consultation with a healthcare professional may be needed to adjust the regimen if symptoms persist.


Q: Can elderly patients use Liposic safely?

The use of Liposic is established for both the adult population and the elderly at the recommended standard adult dosage. Regulatory documents do not note specific use restrictions based purely on advanced age.


Q: What does the research evidence indicate about the long-term effectiveness of Liposic?

Official summaries of the clinical data indicate that most key studies on Liposic have had limited follow-up durations. Consequently, long-term outcomes and patterns related to the duration of its effect are not consistently established across studies.


Q: Can Liposic be used after its expiry date?

No. Official regulatory documents strictly mandate that the medicine must not be used after the expiry date (EXP) that is printed on both the tube and the external carton.


Q: What are the consequences of forgetting to close the tube cap tightly?

Official instructions emphasize the importance of closing the container tightly after each use. This is important to keep the tip of the tube as clean as possible and to ensure the product maintains its sterility after first being opened.


Q: Does Liposic contain any oils or fats (medium-chain triglycerides)?

Yes. The list of excipients (inactive ingredients) in the formulation of Liposic includes medium-chain triglycerides (MCTs).


Q: Can Liposic be used for eye fatigue caused by computer use?

The product is intended for the symptomatic treatment of dryness and eye fatigue. Product information for similar Carbomer gels acknowledges that dry eye sensations can be produced by factors like the use of computer screens.


Q: Is Liposic recommended for dry eyes caused by environmental factors like wind or air conditioning?

Yes. Product information for similar Carbomer gels specifically notes that dry eye symptoms may be produced by a drying atmosphere, such as air conditioning, central heating, wind, and sun.


Q: Can Liposic cause a film or residue on the eyelashes or skin?

Official safety information lists eyelid crusting as one of the common side effects. This describes the formation of a residue or film on the eyelid margins after using the gel.


Q: Is Liposic intended to treat symptoms like redness and burning?

The gel is for the symptomatic treatment of dryness, burning, or tiredness of the eyes, by improving the moistening of the ocular surface. (Redness is listed as a rare side effect, not a symptom it treats.)


Q: What is the purpose of the sorbitol in the Liposic formulation?

The formulation includes sorbitol as an excipient. In similar Carbomer preparations, sorbitol is added as a humectant—a substance that helps protect the eye surface by retaining moisture.


Q: What is the role of sodium hydroxide in the gel formulation?

The ingredients list notes that sodium hydroxide is included in the formulation. Its purpose is for pH adjustment, helping to ensure the gel's acidity level is compatible with the eye.


Q: What kind of studies are available regarding the ingredient Carbomer in eye treatments?

Clinical evaluation for the Carbomer 980 ophthalmic gel primarily involves Randomized Controlled Trials (RCTs) and systematic reviews. These studies focus on patient-reported outcomes for dry eye symptoms in adult populations.

How should Liposic be stored and disposed of?

How to Store and Dispose of Liposic?

Strict adherence to storage and disposal guidelines ensures the product's stability and safe use.

Storage Requirements

Liposic should be stored at room temperature. It is essential to protect the container from excessive heat, moisture, and direct sunlight. To maintain product quality, close the container tightly after each use.

Storage Classification Detail
Temperature Room temperature
Protection Avoid excessive heat, moisture, and direct sunlight
In-Use Stability Discard 30 days after first opening

Handling and Disposal

The product's stability is limited once the container is opened; any unused portion must be discarded 30 days after first opening. All medications, including Liposic, must be stored safely, out of the reach and sight of children and pets. For proper disposal, unused or expired medication should be returned to a pharmacy or healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Liposic found in:

A-Z Index: